Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection

Abstract Background Bloodstream infections (BSIs) represent one of the most severe and clinically important conditions in the hospital setting. We have organized an interdisciplinary antimicrobial stewardship team (AST) at our hospital and performed consultations focusing on BSI patients since 2013....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016-02, Vol.22 (2), p.90-95
Hauptverfasser: Maeda, Masayuki, Takuma, Takahiro, Seki, Haruka, Ugajin, Kazuhisa, Naito, Yuika, Yoshikawa, Masayuki, Yamanaka, Ayumi, Oto, Yuji, Minemura, Atsuko, Shoji, Hisashi, Ishino, Keiko, Niki, Yoshihito
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 95
container_issue 2
container_start_page 90
container_title Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
container_volume 22
creator Maeda, Masayuki
Takuma, Takahiro
Seki, Haruka
Ugajin, Kazuhisa
Naito, Yuika
Yoshikawa, Masayuki
Yamanaka, Ayumi
Oto, Yuji
Minemura, Atsuko
Shoji, Hisashi
Ishino, Keiko
Niki, Yoshihito
description Abstract Background Bloodstream infections (BSIs) represent one of the most severe and clinically important conditions in the hospital setting. We have organized an interdisciplinary antimicrobial stewardship team (AST) at our hospital and performed consultations focusing on BSI patients since 2013. This study aimed to evaluate the impact of AST interventions on the diagnosis, treatment, and clinical outcomes of BSI patients. Methods We conducted a retrospective quasi-experimental study of BSI patients at a single Japanese university hospital. AST provided recommendations to attending physicians regarding appropriate diagnosis, therapy, and management of BSI patients after reviewing medical charts. Results We identified a total of 308 cases of BSI from January to December, 2012 (pre-intervention group) and 324 cases of BSI from April, 2013 to March, 2014 (post-intervention group). No significant differences in the in-hospital mortality or 30-day mortality rates were observed between both the groups. Inappropriate therapy was initiated in a significantly lower proportion of patients in the post-intervention group (18.5% vs. 11.4%; P = 0.012). Multivariate analysis confirmed that inappropriate therapy was significantly associated with in-hospital mortality (odds ratio, 2.62; 95% confidence interval, 1.42–4.82; P = 0.002). Conclusions An interdisciplinary AST intervention approach decreases the use of inappropriate therapy and may improve clinical outcomes in BSI patients.
doi_str_mv 10.1016/j.jiac.2015.11.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1805504801</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1341321X15002615</els_id><sourcerecordid>1760887090</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-5033c62806dcdda4d1d462015fb36784d9890263edbbed1754671d62c1cc7e153</originalsourceid><addsrcrecordid>eNqFkk9rFTEUxQdRbK1-AReSpZuZ5s6fTB6IIKVVoeBCBXchk9yhGWeSZ5JpeZ_BL-0dXuvCRYVAAjnnJPmdFMVr4BVwEOdTNTltqppDVwFUnLdPilNom77se8mf0rppoWxq-HFSvEhp4hz6TsrnxUkthGzqtjktfl-OI5rMwsiczxhv0WcXfGLDgWlPI7vFmRgGp2eWMt7paNON27OMemHBMzM77wxtmrDGhOSwDE3wgWwsrNmEBSma7XV2lJ3Yncs3bJhDsCnHLcT57QZ06Mvi2ajnhK_u57Pi-9Xlt4tP5fWXj58vPlyXphUylx1vGiNqyYU11urWgm3FBmEcGtHL1u7kjteiQTsMaOnJrejBitqAMT1C15wVb4-5-xh-rZiyWlwyOM_aY1iTAsm7jreSw_-lveBS9nzHSVofpUQrpYij2ke36HhQwNXWl5rU1pfarqoAFPVFpjf3-euwoP1reSiIBO-OAiQgtw6jSoY4GrQuEjVlg3s8__0_9oe-fuIB00SdeUKtQKVacfV1-zHbh4GOE0Ji9QdAHL21</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760887090</pqid></control><display><type>article</type><title>Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Maeda, Masayuki ; Takuma, Takahiro ; Seki, Haruka ; Ugajin, Kazuhisa ; Naito, Yuika ; Yoshikawa, Masayuki ; Yamanaka, Ayumi ; Oto, Yuji ; Minemura, Atsuko ; Shoji, Hisashi ; Ishino, Keiko ; Niki, Yoshihito</creator><creatorcontrib>Maeda, Masayuki ; Takuma, Takahiro ; Seki, Haruka ; Ugajin, Kazuhisa ; Naito, Yuika ; Yoshikawa, Masayuki ; Yamanaka, Ayumi ; Oto, Yuji ; Minemura, Atsuko ; Shoji, Hisashi ; Ishino, Keiko ; Niki, Yoshihito</creatorcontrib><description>Abstract Background Bloodstream infections (BSIs) represent one of the most severe and clinically important conditions in the hospital setting. We have organized an interdisciplinary antimicrobial stewardship team (AST) at our hospital and performed consultations focusing on BSI patients since 2013. This study aimed to evaluate the impact of AST interventions on the diagnosis, treatment, and clinical outcomes of BSI patients. Methods We conducted a retrospective quasi-experimental study of BSI patients at a single Japanese university hospital. AST provided recommendations to attending physicians regarding appropriate diagnosis, therapy, and management of BSI patients after reviewing medical charts. Results We identified a total of 308 cases of BSI from January to December, 2012 (pre-intervention group) and 324 cases of BSI from April, 2013 to March, 2014 (post-intervention group). No significant differences in the in-hospital mortality or 30-day mortality rates were observed between both the groups. Inappropriate therapy was initiated in a significantly lower proportion of patients in the post-intervention group (18.5% vs. 11.4%; P = 0.012). Multivariate analysis confirmed that inappropriate therapy was significantly associated with in-hospital mortality (odds ratio, 2.62; 95% confidence interval, 1.42–4.82; P = 0.002). Conclusions An interdisciplinary AST intervention approach decreases the use of inappropriate therapy and may improve clinical outcomes in BSI patients.</description><identifier>ISSN: 1341-321X</identifier><identifier>EISSN: 1437-7780</identifier><identifier>DOI: 10.1016/j.jiac.2015.11.004</identifier><identifier>PMID: 26683243</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Aged ; Anti-Bacterial Agents - administration &amp; dosage ; Antimicrobial stewardship team ; Appropriate therapy ; Bacteremia - drug therapy ; Bacteremia - mortality ; Bloodstream infection ; Communicable Diseases - drug therapy ; Communicable Diseases - mortality ; Cross Infection - drug therapy ; Cross Infection - mortality ; Female ; Hematology, Oncology and Palliative Medicine ; Hospital Mortality ; Hospitals, University ; Humans ; Male ; Retrospective Studies</subject><ispartof>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-02, Vol.22 (2), p.90-95</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-5033c62806dcdda4d1d462015fb36784d9890263edbbed1754671d62c1cc7e153</citedby><cites>FETCH-LOGICAL-c468t-5033c62806dcdda4d1d462015fb36784d9890263edbbed1754671d62c1cc7e153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26683243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maeda, Masayuki</creatorcontrib><creatorcontrib>Takuma, Takahiro</creatorcontrib><creatorcontrib>Seki, Haruka</creatorcontrib><creatorcontrib>Ugajin, Kazuhisa</creatorcontrib><creatorcontrib>Naito, Yuika</creatorcontrib><creatorcontrib>Yoshikawa, Masayuki</creatorcontrib><creatorcontrib>Yamanaka, Ayumi</creatorcontrib><creatorcontrib>Oto, Yuji</creatorcontrib><creatorcontrib>Minemura, Atsuko</creatorcontrib><creatorcontrib>Shoji, Hisashi</creatorcontrib><creatorcontrib>Ishino, Keiko</creatorcontrib><creatorcontrib>Niki, Yoshihito</creatorcontrib><title>Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection</title><title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</title><addtitle>J Infect Chemother</addtitle><description>Abstract Background Bloodstream infections (BSIs) represent one of the most severe and clinically important conditions in the hospital setting. We have organized an interdisciplinary antimicrobial stewardship team (AST) at our hospital and performed consultations focusing on BSI patients since 2013. This study aimed to evaluate the impact of AST interventions on the diagnosis, treatment, and clinical outcomes of BSI patients. Methods We conducted a retrospective quasi-experimental study of BSI patients at a single Japanese university hospital. AST provided recommendations to attending physicians regarding appropriate diagnosis, therapy, and management of BSI patients after reviewing medical charts. Results We identified a total of 308 cases of BSI from January to December, 2012 (pre-intervention group) and 324 cases of BSI from April, 2013 to March, 2014 (post-intervention group). No significant differences in the in-hospital mortality or 30-day mortality rates were observed between both the groups. Inappropriate therapy was initiated in a significantly lower proportion of patients in the post-intervention group (18.5% vs. 11.4%; P = 0.012). Multivariate analysis confirmed that inappropriate therapy was significantly associated with in-hospital mortality (odds ratio, 2.62; 95% confidence interval, 1.42–4.82; P = 0.002). Conclusions An interdisciplinary AST intervention approach decreases the use of inappropriate therapy and may improve clinical outcomes in BSI patients.</description><subject>Aged</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Antimicrobial stewardship team</subject><subject>Appropriate therapy</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteremia - mortality</subject><subject>Bloodstream infection</subject><subject>Communicable Diseases - drug therapy</subject><subject>Communicable Diseases - mortality</subject><subject>Cross Infection - drug therapy</subject><subject>Cross Infection - mortality</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hospital Mortality</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Male</subject><subject>Retrospective Studies</subject><issn>1341-321X</issn><issn>1437-7780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk9rFTEUxQdRbK1-AReSpZuZ5s6fTB6IIKVVoeBCBXchk9yhGWeSZ5JpeZ_BL-0dXuvCRYVAAjnnJPmdFMVr4BVwEOdTNTltqppDVwFUnLdPilNom77se8mf0rppoWxq-HFSvEhp4hz6TsrnxUkthGzqtjktfl-OI5rMwsiczxhv0WcXfGLDgWlPI7vFmRgGp2eWMt7paNON27OMemHBMzM77wxtmrDGhOSwDE3wgWwsrNmEBSma7XV2lJ3Yncs3bJhDsCnHLcT57QZ06Mvi2ajnhK_u57Pi-9Xlt4tP5fWXj58vPlyXphUylx1vGiNqyYU11urWgm3FBmEcGtHL1u7kjteiQTsMaOnJrejBitqAMT1C15wVb4-5-xh-rZiyWlwyOM_aY1iTAsm7jreSw_-lveBS9nzHSVofpUQrpYij2ke36HhQwNXWl5rU1pfarqoAFPVFpjf3-euwoP1reSiIBO-OAiQgtw6jSoY4GrQuEjVlg3s8__0_9oe-fuIB00SdeUKtQKVacfV1-zHbh4GOE0Ji9QdAHL21</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Maeda, Masayuki</creator><creator>Takuma, Takahiro</creator><creator>Seki, Haruka</creator><creator>Ugajin, Kazuhisa</creator><creator>Naito, Yuika</creator><creator>Yoshikawa, Masayuki</creator><creator>Yamanaka, Ayumi</creator><creator>Oto, Yuji</creator><creator>Minemura, Atsuko</creator><creator>Shoji, Hisashi</creator><creator>Ishino, Keiko</creator><creator>Niki, Yoshihito</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160201</creationdate><title>Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection</title><author>Maeda, Masayuki ; Takuma, Takahiro ; Seki, Haruka ; Ugajin, Kazuhisa ; Naito, Yuika ; Yoshikawa, Masayuki ; Yamanaka, Ayumi ; Oto, Yuji ; Minemura, Atsuko ; Shoji, Hisashi ; Ishino, Keiko ; Niki, Yoshihito</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-5033c62806dcdda4d1d462015fb36784d9890263edbbed1754671d62c1cc7e153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Antimicrobial stewardship team</topic><topic>Appropriate therapy</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteremia - mortality</topic><topic>Bloodstream infection</topic><topic>Communicable Diseases - drug therapy</topic><topic>Communicable Diseases - mortality</topic><topic>Cross Infection - drug therapy</topic><topic>Cross Infection - mortality</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hospital Mortality</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Male</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maeda, Masayuki</creatorcontrib><creatorcontrib>Takuma, Takahiro</creatorcontrib><creatorcontrib>Seki, Haruka</creatorcontrib><creatorcontrib>Ugajin, Kazuhisa</creatorcontrib><creatorcontrib>Naito, Yuika</creatorcontrib><creatorcontrib>Yoshikawa, Masayuki</creatorcontrib><creatorcontrib>Yamanaka, Ayumi</creatorcontrib><creatorcontrib>Oto, Yuji</creatorcontrib><creatorcontrib>Minemura, Atsuko</creatorcontrib><creatorcontrib>Shoji, Hisashi</creatorcontrib><creatorcontrib>Ishino, Keiko</creatorcontrib><creatorcontrib>Niki, Yoshihito</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maeda, Masayuki</au><au>Takuma, Takahiro</au><au>Seki, Haruka</au><au>Ugajin, Kazuhisa</au><au>Naito, Yuika</au><au>Yoshikawa, Masayuki</au><au>Yamanaka, Ayumi</au><au>Oto, Yuji</au><au>Minemura, Atsuko</au><au>Shoji, Hisashi</au><au>Ishino, Keiko</au><au>Niki, Yoshihito</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection</atitle><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle><addtitle>J Infect Chemother</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>22</volume><issue>2</issue><spage>90</spage><epage>95</epage><pages>90-95</pages><issn>1341-321X</issn><eissn>1437-7780</eissn><abstract>Abstract Background Bloodstream infections (BSIs) represent one of the most severe and clinically important conditions in the hospital setting. We have organized an interdisciplinary antimicrobial stewardship team (AST) at our hospital and performed consultations focusing on BSI patients since 2013. This study aimed to evaluate the impact of AST interventions on the diagnosis, treatment, and clinical outcomes of BSI patients. Methods We conducted a retrospective quasi-experimental study of BSI patients at a single Japanese university hospital. AST provided recommendations to attending physicians regarding appropriate diagnosis, therapy, and management of BSI patients after reviewing medical charts. Results We identified a total of 308 cases of BSI from January to December, 2012 (pre-intervention group) and 324 cases of BSI from April, 2013 to March, 2014 (post-intervention group). No significant differences in the in-hospital mortality or 30-day mortality rates were observed between both the groups. Inappropriate therapy was initiated in a significantly lower proportion of patients in the post-intervention group (18.5% vs. 11.4%; P = 0.012). Multivariate analysis confirmed that inappropriate therapy was significantly associated with in-hospital mortality (odds ratio, 2.62; 95% confidence interval, 1.42–4.82; P = 0.002). Conclusions An interdisciplinary AST intervention approach decreases the use of inappropriate therapy and may improve clinical outcomes in BSI patients.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>26683243</pmid><doi>10.1016/j.jiac.2015.11.004</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1341-321X
ispartof Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-02, Vol.22 (2), p.90-95
issn 1341-321X
1437-7780
language eng
recordid cdi_proquest_miscellaneous_1805504801
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Anti-Bacterial Agents - administration & dosage
Antimicrobial stewardship team
Appropriate therapy
Bacteremia - drug therapy
Bacteremia - mortality
Bloodstream infection
Communicable Diseases - drug therapy
Communicable Diseases - mortality
Cross Infection - drug therapy
Cross Infection - mortality
Female
Hematology, Oncology and Palliative Medicine
Hospital Mortality
Hospitals, University
Humans
Male
Retrospective Studies
title Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A26%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20interventions%20by%20an%20antimicrobial%20stewardship%20team%20on%20clinical%20course%20and%20economic%20outcome%20in%20patients%20with%20bloodstream%20infection&rft.jtitle=Journal%20of%20infection%20and%20chemotherapy%20:%20official%20journal%20of%20the%20Japan%20Society%20of%20Chemotherapy&rft.au=Maeda,%20Masayuki&rft.date=2016-02-01&rft.volume=22&rft.issue=2&rft.spage=90&rft.epage=95&rft.pages=90-95&rft.issn=1341-321X&rft.eissn=1437-7780&rft_id=info:doi/10.1016/j.jiac.2015.11.004&rft_dat=%3Cproquest_cross%3E1760887090%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760887090&rft_id=info:pmid/26683243&rft_els_id=S1341321X15002615&rfr_iscdi=true